Treatment of Patients With Blepharitis and Facial Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

July 31, 2009

Conditions
BlepharitisMeibomianitisDry Eye
Interventions
DRUG

COL-101 (doxycycline, USP) capsules

40mg, once per day for 84 days

DRUG

placebo

sugar capsule

Trial Locations (8)

11563

Marguerite McDonald, MD, Lynbrook

19004

Anita Nevyas-Wallace, MD, Bala-Cynwyd

34103

Warren Scherer, MD, Naples

40202

Kentucky Lions Eye Center, Louisville

63110

Washington University School of Medicine, St Louis

72212

Pleasant Valley Ophthalmology, Little Rock

73104

Dean McGee Eye Institute, Oklahoma City

84041

Tanner Clinic, Layton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT00560703 - Treatment of Patients With Blepharitis and Facial Rosacea | Biotech Hunter | Biotech Hunter